Years of Life Lost From Metastatic Prostate Cancer According to Treatment Era and Race/Ethnicity. [PDF]
Quarta L +17 more
europepmc +1 more source
Targeting the PI3K/AKT pathway in prostate cancer: the role of PTEN deficiency and biomarker-guided therapy. [PDF]
Staton A, Abel M, Figg WD.
europepmc +1 more source
The rising cost of litigation for urological tumors in the Brazilian Public Health System: an analysis of e-NatJus technical notes (2020-2026). [PDF]
Korkes F, Pedrotti C, Tocci F.
europepmc +1 more source
A Phase I trial of the anti-IL23 monoclonal antibody tildrakizumab, in combination with abiraterone acetate, for the treatment of metastatic castration-resistant prostate cancer. [PDF]
Chandran K +26 more
europepmc +1 more source
A systematic review and meta-analysis of treatment-induced hypertension risks from androgen receptor pathway inhibitors in randomized controlled trials for prostate cancer. [PDF]
Gong Q, Ge F, Chen T.
europepmc +1 more source
Pharmacokinetics, safety, and efficacy of fuzuloparib in combination with abiraterone acetate and prednisone in patients with metastatic castration-resistant prostate cancer: a phase 1 dose escalation and expansion study. [PDF]
Dai T +11 more
europepmc +1 more source
Quality of Life and Psychological Factors in Patients with Metastatic Prostate Cancer Receiving Androgen Receptor-Targeted Therapies: A Prospective Cross-Sectional Real-World Study. [PDF]
Çelik S +5 more
europepmc +1 more source
Bacterial Meningitis Following Robot-Assisted Radical Prostatectomy After Neoadjuvant Precision Oncology-Directed Therapy: A Case Report. [PDF]
Allen T +3 more
europepmc +1 more source
Risk of fracture following androgen receptor pathway inhibitors in men with advanced prostate cancer. [PDF]
Lu-Yao G +11 more
europepmc +1 more source
Impact of PSA Nadir on Outcomes in Metastatic Hormone-Sensitive Prostate Cancer: A Systematic Review and Reconstructed Individual Patient Data Meta-analysis. [PDF]
Di Civita MA +12 more
europepmc +1 more source

